Edwards Lifesciences Completes Acquisition Of Valtech Cardio

IRVINE, Calif., Jan. 23, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has closed its acquisition of Valtech Cardio Ltd., a privately held company based in Israel and developer of the Cardioband System for transcatheter repair of the mitral and tricuspid valves. Edwards announced in November that it had signed an agreement to acquire Valtech. Under the terms of the merger agreement, Edwards paid $340 million in stock and cash for Valtech at closing, subject to typical adjustments. In addition, there is the potential for up to $350 million i

Edwards Lifesciences Completes Acquisition Of Valtech Cardio

IRVINE, Calif., Jan. 23, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has closed its acquisition of Valtech Cardio Ltd., a privately held company based in Israel and developer of the Cardioband System for transcatheter repair of the mitral and tricuspid valves. Edwards announced in November that it had signed an agreement to acquire Valtech. Under the terms of the merger agreement, Edwards paid $340 million in stock and cash for Valtech at closing, subject to typical adjustments. In addition, there is the potential for up to $350 million i

Recent Posts
Featured Posts
Archive
Search By Tags

Contact Info

6 Yoni Netanyahu Street
Or Yehuda, 60376, Israel

Phone: +972 -3- 634 9990 
Fax: +972 -3- 634 9910

 

Map & Directions >>

Portfolio

Life Sciences

Software

 

 

© Peregrine Ventures  |  Terms & Conditions  |  Privacy Policy